Clinical Trial Update: BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update indicating that the BLI1100 study for moderate to severe acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• BLI1100

Snippet

Sponsor: Braintree Laboratories | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED